Corbus Pharma
CRBP----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Corbus Pharma(CRBP) predict that the EBIT is -24.3 M (-22.9%), Miss estimate;the EPS is -1.23 (+11.51%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.02B22.90%
-0.02B12.31%
-0.00B10.59%
EPSExceed expectations
-1.2311.51%
-1.248610.17%
+0.01861.34%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf